News item | 09-01-2025 | 05:00

Today, Minister Beljaarts of Economic Affairs received a confirmation letter from Cedars Sinai Intellectual Property Company. This renowned investment fund, based in Los Angeles, focuses on innovative solutions in the Life Sciences & Health sector. With this letter, Cedars-Sinai confirms their intention to establish a fund in the Netherlands in collaboration with the Netherlands Foreign Investment Agency. The signing took place during a working visit by Minister Beljaarts to the west coast of the United States, during which technological innovation and economic cooperation are central.

During the signing, Minister Beljaarts emphasized the importance of transatlantic ties and the shared ambition to make healthcare more accessible and effective.

Minister Beljaarts (Economic Affairs): “Dutch companies are at the forefront of technological innovation in healthcare. By working with Cedars-Sinai, we can bring these innovations to the global market more quickly while contributing to better healthcare solutions for patients.”

James D. Laur (CEO, Cedars Sinai Intellectual Property Company): “In addition to strengthening our already established relationships with stakeholders in the dynamic Dutch healthcare and biomedical sectors, this collaboration will stimulate the development of startups from the Netherlands by connecting them with the resources and expertise of Cedars-Sinai Tech Ventures. This will help companies better understand and leverage the market and opportunities in the United States.”

Cedars Sinai Intellectual Property Company

The fund is known worldwide for its focus on breakthrough technologies, including medical devices, biotechnology and digital health solutions. This collaboration gives Dutch companies and start-ups access to a strategic network, knowledge and financing options that contribute to accelerating innovations and growth in this crucial sector. The announcement of Cedars-Sinai Technology Ventures to establish itself in the Netherlands is a concrete step in the ambition to position the Netherlands as an innovation hub. And is part of a broader strategy of the Ministry of Economic Affairs to strengthen ties with Silicon Valley and the American west coast. There are more than 3,000 innovative Life Sciences & Health companies active in the Netherlands with an economic impact of approximately 7 billion euros. The Dutch LSH sector received an extra boost with the move of the European Medicines Agency (EMA) to Amsterdam in 2019.

USA trip

The announcement was delivered in Silicon Valley. And took place in the context of the US trip of Minister Beljaarts. The purpose of the trip is to firmly position Dutch tech companies and startups internationally and to strengthen cooperation with American companies. The trip runs from Monday 6 to Thursday 9 January. Together with Dutch entrepreneurs, the minister will visit Phoenix, Arizona, the largest global technology fair CES in Las Vegas and Silicon Valley near San Francisco. The working visit also includes discussions with prominent technology companies and investors, focusing on topics such as artificial intelligence, semiconductor technology and cybersecurity. The minister also spoke with representatives of Dutch companies active in Silicon Valley to discuss how the government can support them in their growth ambitions.

ttn-17